Nature-inspired novel drug design paradigm using nanosilver: Efficacy on multi-drug-resistant clinical isolates of tuberculosis

Current Microbiology

Volumn 62, Issue 3, 2011, Pages 715-726

  Seth, Dipankar ^a   Choudhury, Samrat Roy ^a   Pradhan, Saheli ^a   Gupta, Siddhartha ^b   Palit, Debjani ^c   Das, Sumistha ^a   Debnath, Nitai ^a   Goswami, Arunava ^a  

^a INDIAN STATISTICAL INSTITUTE   (India)

^b INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^c Pathowynd Clinical Laboratory Inc   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; ISONIAZID; POVIDONE; RIFAMPICIN; SILVER NANOPARTICLE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOCOMPATIBILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DESIGN; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NANOENCAPSULATION; NANOTECHNOLOGY; NONHUMAN; PERITONEAL FLUID; PLEURA FLUID; PRIORITY JOURNAL; SPUTUM CULTURE;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG STABILITY; HUMANS; HYDROGEN-ION CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NANOPARTICLES; SILVER; TUBERCULOSIS, MULTIDRUG-RESISTANT;

BOMBYX MORI NPV; BOVINAE;

EID: 79954449804     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-010-9770-7     Document Type: Article

References (24)

1. A Goswami S Singh VD Redkar S Sharma 1997 Characterization of P0, a ribosomal phosphoprotein of Plasmodium falciparum antibody against amino-terminal domain inhibits parasite growth J Biol Chem 272 18 12138 12143 9115284 10.1074/jbc.272.18.12138 1:CAS:528:DyaK2sXivF2qsL0%3D (Pubitemid 27202795)
2. S Sharma A Goswami NJ Singh L Kabilan SS Deodhar 1996 Immunogenicity of the nonrepetitive regions of the circumsporozoite protein of Plasmodium knowlesi Am J Trop Med Hyg 55 6 635 641 9025690 1:CAS:528:DyaK2sXhsVOguro%3D (Pubitemid 27110999)
3. A Goswami S Chatterjee S Sharma 1996 Cloning of a ribosomal phosphoprotein P0 gene homologue from Plasmodium falciparum Mol Biochem Parasitol (Elsevier) 82 1 117 120 10.1016/0166-6851(96)02717-X 1:CAS:528:DyaK28Xms1elsbg%3D (Pubitemid 26376810)
4. S Singh A Sehgal A Goswami S Waghmare T Chakrabarty S Sharma 2002 Surface expression of the conserved ribosomal protein P0 on parasite and other cells Mol Biochem Parasitol (Elsevier) 119 1 121 124 10.1016/S0166-6851(01)00394-2 1:CAS:528:DC%2BD38XitF2h (Pubitemid 34038032)
5. A Rahman D Seth SK Mukhopadhyaya RL Brahmachary C Ulrichs A Goswami 2009 Surface functionalized amorphous nanosilica and microsilica with nanopores as promising tools in biomedicine Naturwissenschaften 96 31 38 18791695 10.1007/s00114-008-0445-1 1:CAS:528:DC%2BD1cXhsV2qurfF
6. A Goswami A Rahman N Biswas C Ulrichs C Büttner RL Bramhachary A Datta 2009 Nanoparticle-virus complex shows enhanced immunological effect against baculovirus J Nanosci Nanotechnol 9 1 5 10.1166/jnn.2009.J01a
7. C Ulrichs B Welke T Mucha-Pelzer A Goswami I Mewis 2008 Effect of solid particulate matter deposits on vegetation: a review Function Plant Sci Biotechnol 2 1 56 62
8. JL Elechiguerra JL Burt JR Morones AC Bragado X Gao HH Lara MJ Yacaman 2005 Interaction of silver nanoparticles with HIV-1 J Nanobiotechnol 3 6 10.1186/1477-3155-3-6 (Pubitemid 41460801)
9. JS Kim 2007 Reduction of Silver Nitrate in Ethanol by Poly(N-vinylpyrrolidone) J Ind Eng Chem 13 4 566 570 1:CAS:528: DC%2BD2sXoslKqtro%3D
10. GP Kubica WE Dye ML Cohn G Middlebrook 1963 Sputum digestion and decontamination with N-acetyl L- cysteine sodium hydroxide for culture of bacteria Am Rev Respir Dis 87 775 779 13927224 1:STN:280:DyaF387hvVylsw%3D%3D
11. Forbes BA, Sahm DF, Weissfeld AS (eds) (2004) Baily & Scott's diagnostic microbiology, 2nd edn. Mosby Elsevier, St louis, MO, pp 488-506
12. World Health Organisation (2003) Treatment of tuberculosis: guidelines for national programmes, 3rd edn. World Health Organisation Geneva, Switzerland
13. Wan B, Rayner A, Harris G (2006) Mycobacterium. In: College JG, Fraser AG, Marmion BP, Simmons A (eds) Mackie & Mc Cartney's practical medical microbiology, 14th edn. Churchill Livingstone, London, UK, pp 332-335
14. V Sritharan RH Barker 1991 A simple method for diagnosis of M. tuberculosis infection in clinical samples using PCR Mol Cell Probes 5 585 595 10.1016/S0890-8508(06)80011-3
15. D Bandopadhyay S Gupta S Banerjee D Ray S Bhattacharya B Bhattacharya 2008 Adenosine deaminase estimation and multiplex polymerase chain reaction in diagnosis of extra-pulmonary tuberculosis Int J Tuberc Lung Dis 12 10 1203 1208
16. World Health Organization. Global Tuberculosis Control, Surveillance, Planning, Financing. WHO/CDS/Tuberculosis/2002.295
17. World Health Organization. Global Tuberculosis Control, Surveillance, Planning, Financing. WHO/HTM/Tuberculosis/2005.349.Geneva, Switzerland: WHO, 2005
18. World Health Organization. Prevalence and incidence of Tuberculosis in India: A comprehensive Review, 1997. World Health Organization. Global Tuberculosis Control, Surveillance, Planning, Financing. WHO/CDS/Tuberculosis/ 2002.295,1998
19. P Barnes AB Blotch BT Davidson DE Snyder Jr 1991 Tuberculosis in patients with immunodeficiency virus infection N Eng J Med 324 1644 1650 10.1056/NEJM199106063242307 1:STN:280:DyaK3M3jt1Glsg%3D%3D
20. SW Dooley WR Jarvis WJ Martone DE Snyder 1992 Multidrug resistant tuberculosis (editorial) Ann Intern Med 117 191 196 1352093
21. Raviglione MC, O'Brien RJ (1998) Tuberculosis. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL (eds) Harrison's principles of internal medicine, 14th edn. Mc Graw Hill Companies, Inc, Columbus, USA, pp 1010-1016
22. X Chen J Schluesener 2008 Nanosilver: a nanoproduct in medical application Toxicol Lett 176 1 1 12 18022772 10.1016/j.toxlet.2007.10.004 1:CAS:528:DC%2BD2sXhsVCgsrnI (Pubitemid 350251066)
23. F Furno KS Morley B Wong BL Sharp PL Arnold SM Howdle R Baystonl PD Brown PD Winship HJ Reid 2004 Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? Nanomedicine: Nanotechnol Biol Med 3 1 95 101
24. S Shrivastava T Bera A Roy G Singh P Ramachandrarao D Dash 2007 Characterization of enhanced antibacterial effects of novel silver nanoparticles Nanotechnology 18 9 16 10.1088/0957-4484/18/22/225103 225103 (Pubitemid 46718713)